Oh, and have a good Christmas all. Look forward to a rapid run to positive cash flows in 2024, that OCC would already be enjoying were it not for it's R&D expenditure, which is of course mainly getting Remplir and ATI to market in the US. An investment of capital and cash flows that none of us would disagree with.
l
Ann: Orthocell Board Change, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $80.59M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.0¢ | $24.44K | 62.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 649 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |